Table 2 The baseline demographics and clinical features of patients.
Variable | FLIPUS (n = 57) | PSWD (n = 57) | P value |
|---|---|---|---|
Age, years | 62.28 ± 10.88 | 59.93 ± 8.97 | 0.211 |
Women, no. (%) | 42 (73.68%) | 45 (78.95%) | 0.660 |
BMI, kg/m2 | 25.18 ± 3.26 | 25.29 ± 2.85 | 0.854 |
Duration of disease, months | 120.32 ± 74.88 | 118.54 ± 89.73 | 0.909 |
Kellgren–Lawrence grade, no. (%) | |||
Grade I | 4 (7.01%) | 6 (10.53%) | 0.205 |
Grade II | 40 (70.18%) | 45 (78.94%) | |
Grade III | 13 (22.81%) | 6 (10.53%) | |
Primary outcome | |||
WOMAC | |||
Total | 34.49 ± 10.26 | 33.70 ± 7.91 | 0.646 |
Pain | 6.40 ± 2.15 | 7.44 ± 2.61 | 0.551 |
Stiffness | 2.35 ± 1.13 | 2.56 ± 1.02 | 0.558 |
Physical function | 23.89 ± 8.37 | 25.54 ± 6.58 | 0.688 |
Secondary outcomes | |||
NRS score | 5.51 ± 1.28 | 5.81 ± 1.06 | 0.825 |
GRC score | − 2 (2) | − 1 (3) | 0.066 |
ROM, degree | 127.39 ± 5.92 | 126.23 ± 6.57 | 0.895 |
TUG test score | 12.91 ± 2.45 | 12.60 ± 2.33 | 0.296 |